New England Research & Management, Inc. Penumbra Inc Transaction History
New England Research & Management, Inc.
- $208 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding PEN
# of Institutions
383Shares Held
29.6MCall Options Held
285KPut Options Held
168K-
Black Rock Inc. New York, NY4.26MShares$822 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.7MShares$714 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$584 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.28MShares$248 Million1.46% of portfolio
-
State Street Corp Boston, MA1.23MShares$238 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $7.32B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...